Lymphokine-activated killer (LAK) cells: VI. NK1.1+, CD3+ LAK effectors are derived from CD4−, CD8−, NK1.1− precursors

This publication has 23 references indexed in Scilit:

• Cyclosporin A inhibition of interleukin 2 gene expression, but not natural killer cell proliferation, after interferon induction in vivo.
  The Journal of Experimental Medicine, 1990
• Murine natural killer cells express the Ly24 (Pgp-1) marker on their surface
  Cellular Immunology, 1990
• Novel T-Lymphocyte Population in Combined Immunodeficiency with Features of Graft-versus-Host Disease
  New England Journal of Medicine, 1989
• Toxicity and therapeutic efficacy of high-dose interleukin 2. In vivo infusion of antibody to NK-1.1 attenuates toxicity without compromising efficacy against murine leukemia.
  The Journal of Experimental Medicine, 1989
• Human natural killer cells isolated from peripheral blood do not rearrange T cell antigen receptor beta chain genes.
  The Journal of Experimental Medicine, 1986
• Functional studies on the precursors of human lymphokine-activated killer cells
  Cellular Immunology, 1985
• Association of lpr gene with graft-vs.-host disease-like syndrome.
  The Journal of Experimental Medicine, 1985
• Analysis of T-Cell Receptor Gene Rearrangement and Expression in Human Natural Killer Clones
  Science, 1985
• THE DIFFERENTIAL INHIBITORY EFFECTS EXERTED BY CYCLOSPORINE AND HYDROCORTISONE ON THE ACTIVATION OF HUMAN CYTOTOXIC LYMPHOCYTES BY RECOMBINANT INTERLEUKIN-2 VERSUS ALLOSPECIFIC CTL
  Transplantation, 1985
• Gene rearrangement in cells with natural killer activity and expression of the β-chain of the T-cell antigen receptor
  Nature, 1985